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Health‑related quality of life (HRQoL)
in a population at risk of type 2 diabetes:
a cross‑sectional study in two Latin American
cities
Luis A. Anillo Arrieta1,2* , Tania Acosta Vergara2, Rafael Tuesca2,3, Sandra Rodríguez Acosta4,
Karen C. Flórez Lozano1, Pablo Aschner5,6,7, Rafael Gabriel8,9, Sandra De La Rosa2, Julieth P. Nieto Castillo2 and
Noël C. Barengo10,11,12

Abstract
Purpose: The purpose of this study was to describe the health-related quality of life (HRQoL) characteristics in a
population at risk of developing type 2 diabetes in Barranquilla and Bogotá, Colombia.
Methods: A cross-sectional study with 1135 participants older than 30 years-of-age recruited in Bogotá D.C., and Barranquilla by cluster sampling in 2018 to 2019. The Finnish Diabetes Risk Score (FINDRISC) was used to detect participants at risk of developing type 2 diabetes (T2D). HRQoL was assessed using the EQ-5D-3L questionnaire. Unadjusted
and adjusted logistic regression models were used to calculate odds ratios (OR) and their corresponding 95% confidence intervals CI).
Results: Moderate or extreme problems appeared more frequently in the dimensions of Pain/Discomfort (60.8%)
and Anxiety/Depression (30.8%). The mean score of the EQ-VAS was 74.3 (± 17.3), significantly larger in the state of
complete health (11111) compared with those with problems in more than one of the quality-of-life dimensions.
Being female and living in Bogota D.C., were associated with greater odds of reporting problems in the Pain (OR 1.6;
95% CI 1.2–2.2) and Discomfort dimensions (OR 1.6; 95% CI 1.2–2.0) respectively and Anxiety/Depression (OR 1.9; 95%
CI 1.3–2.7), (OR 9.1; 95% CI 6.6–12.4), respectively.
Conclusions: As living place and sex were associated with dimensions of Pain/Discomfort and Anxiety/Depression
in the HRQoL in people at risk of T2D, greater attention should be paid to these determinants of HRQoL to design and
reorient strategies with a territorial and gender perspective to achieve better health outcomes.
Plain English summary: Diabetes is one of the four non-communicable diseases with increasing prevalence in the
world, which has made it a serious public health problem. In Colombia, in 2019 diabetes affected 8.4% of the Colombian adult population and more than one million Colombian adults of this age group have hidden or undetected
diabetes. This disease is not only characterized by increased premature mortality, loss of productivity, and economic
impact, but it also involves a deterioration in the quality of life of people with diabetes with their respective families.
However, very Little is known about health-related quality of life (HRQoL) in a population at risk or with prediabetes.
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This study has evaluated the quality of life in patients at risk of diabetes and their behavior with some variables as
sociodemographic, lifestyle, history, and established their difference in two territories of the Colombian Caribbean.
The results of this study indicate that the HRQoL of people at risk of type 2 diabetes is affected by factors such as gender, city, dysglycemia, medication for hypertension and education level. Therefore, greater attention should be paid to
these determinants of HRQL to design and implement strategies that reduce this risk of developing type 2 diabetes,
prevent prediabetes and improve the quality of life in prediabetic or diabetic patients.
Keywords: Health related quality of life, Hyperglycemia, Type 2 diabetes, Risk factors

Introduction
It is estimated that 463 million adults around the world
have diabetes and 374 million have prediabetes. It is
expected that by 2045 the numbers of adults with diabetes and prediabetes will be 700 and 548 million, respectively. In Colombia, the prevalence of diabetes in the
adult population is 8.4% and it is estimated that more
than one million have undiagnosed diabetes [1, 2]. Randomized clinical trials have shown the potential to prevent or delay the development of type 2 diabetes (T2D) in
people at risk of developing the disease through lifestyle
changes that included changes in eating habits and physical activity [3–5]. However, the first step in preventing
diabetes is identifying people at risk while they are still in
a normoglycemic state [6].
The measurement of blood glucose levels is the method
commonly used for the identification of subjects at risk
of diabetes, however, it is an invasive, time-consuming
and expensive process, therefore, it is currently available
of the diabetes risk score (FINDRISC) which allows identifying people with future risk of T2D [6, 7]. The FINDRISC scoring system was developed in Finland and is an
instrument that has been adapted and validated in many
countries including ours. In Colombia, a FINDRISC
score ≥ 12 is considered diabetes risk [8, 9].
Several studies have established that T2D significantly
reduces the health-related quality of life (HRQoL) [10–
14]. However, there is little and controversial literature
on HRQoL in patients at risk for T2D [15–19]. Previous
studies describing HRQoL in persons at risk for diabetes
only included participants with impaired glucose tolerance or prediabetes [15–19]. However, these studies did
not include people at future risk of developing T2D that
may still have normal glucose levels [6].
HRQoL is the measure most frequently used to evaluate the impact of chronic illness or its treatment. The use
of generic questionnaires such as the EQ-5D [20–24],
SF-36 [25], and Health Utilities Index [26] have become
the most common methods to establish the effects in
terms of HRQoL. In the recent scientific literature, the
EQ-5D tends to be the most widely used instrument in
cost-utility analyses [27], not only because it is a short
and cognitively simple questionnaire to complete but

also because it is the instrument preferred by evaluation
agencies of health technologies to establish measures of
HRQoL in adults [28, 29]. To our knowledge, there is no
information available on HRQL in a population at risk of
T2D through FINDRISC in Latin America. The objective
of this study was to describe the characteristics of healthrelated quality of life (HRQoL) in a population at risk of
developing type 2 diabetes in Barranquilla and Bogotá,
Colombia.

Materials and methods
Study design and population

This cross-sectional study used baseline information
collected within the PREDICOL project (Evaluation
of a community health program for the prevention of
type 2 diabetes and other cardio-metabolic risk factors
in adults) developed in neighborhoods of two Colombian cities. In Bogotá, the capital city of Colombia with
the largest number of inhabitants (7,743,955 inhabitants
approximately), located in the central region of the country at 2630 m above sea level with a climate that ranges
between 5 and 19 °C, the project It was developed in the
Palermo Sur neighborhood located in the southeast of
the capital, has 50,000 inhabitants and has approximately
23.5 ha of land, mostly mountainous terrain and Barranquilla, the fourth most populated city in the country
with 1,274,250 inhabitants (2.5% of the total population
of Colombia) located in the Colombian Caribbean region
above sea level with an average temperature of 29 °C, was
developed in the El Pueblo neighborhood, located in the
south west of the city with 240,000 inhabitants with flat
land [30].
The study participants were recruited in Bogota and
Barranquilla by cluster sampling [30]. During January
2018 to December 2019 approximately 1350 households
of lower socio-economic strata were visited. All persons
older than 30 years-of-age in each household were asked
to fill in the Finnish Diabetes Risk Score (FINDRISC).
In total, the FINDRISC was applied to 3738 people over
30 years-of-age. Respondents with a FINDRISC ≥ 12
points were invited to the health care centers of each
location for an oral glucose tolerance test (OGTT), managing to establish the glycemic status of 1166 participants
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(55% of the 2118 at risk of T2D). This study excluded people with known type 2 diabetes, cognitive disabilities, or
pregnant women. Further, the records of the participants
with missing data (31 records with some missing data—
2.6%) in the variables used in this analysis and in the FINDRISC, HRQoL and physical activity questionnaires were
excluded. The final sample included 1135 participants
with completed questionnaires and who met previously
defined criteria. This study was registered at ClinicalTrials.gov under the identification number NCT03049839.
The methodology of this study has been published previously in a recent publication [31].

or vegetables, history of high blood glucose, and family
history of T2D [6, 7]. The total risk score is a simple sum
of the individual weights, with a minimum score of 0 and
maximum of 26. This questionnaire has been validated in
various countries including Colombia, and a score of ≥ 12
has been used to define at risk of future T2D [8, 9, 32,
33]. For determining the physical activity (PA) level, the
short version of the International Physical Activity Questionnaire (IPAQ-SV) was used, comprising seven questions addressing the frequency, intensity, and duration
of physical activity during the last 7 days [34–37]. Data
were also collected through a socio-demographic questionnaire that included information on the marital status,
occupation and educational level of the participants.

Non‑invasive measurements

Before the blood glucose measurements, the participants’ HRQoL was assessed using the Spanish version
of the generic EQ-5D-3L questionnaire from the EuroQol group. This questionnaire consists of two parts, the
EQ-5D descriptive component and the visual analog
scale (EQ-VAS) [20, 21]. The descriptive component contains five dimensions: Mobility (MO), Self-Care (SC),
Usual Activities (UA), Pain/Discomfort (P/D), and Anxiety/Depression (A/D). Each dimension consists of three
levels: No problems (1), moderate problems (2), and
extreme or severe problems (3), which are self-reported
by the participant according to their health state. Combination of the digits of all the dimensions generates a
5-digit number that describes the health state of the participant, giving 243 possible states [20, 22]. For example, state 11111 indicates no problem in any of the five
dimensions, whereas state 11122 indicates the following: No problems walking (1), no problems with personal
care (1), no problems with daily activities (2), moderate
pain or discomfort (2), and moderate anxiety or depression (1). Many countries have developed a set of values or
rates for all possible health states of the EQ-5D-3L using
many preference-based techniques, however, Colombia
does not yet have a locally appropriate set of values as
suggested by the EuroQol group [22–24].
The second part of the EQ-5D is the EQ-VAS which
records self-rated health on a millimeter scale ranging
from 0 (worst imaginable health) to 100 (best imaginable
health). The participant had to mark the point on a vertical line that best reflects the assessment of their overall
health state [20, 22]. In this study, due to the absence of
a locally appropriate set of values, the EQ-5D score was
not calculated, therefore only the frequencies of the EQ5D-3L health states were described and the HRQoL of
participants was evaluated using the EQ-VAS.
The risk of T2D was assessed using the FINDRISC,
which consists of eight items: age, body mass index
(BMI), waist circumference, self-report of physical activity of at least 30 min per day, daily consumption of fruits

Invasive measurements

Participants scoring ≥ 12 on the FINDRISC were invited
to an oral glucose tolerance test according to recommendations of the World Health Organization (WHO)
[38, 39]. The test started after 12 h fasting, and the fasting and 2-h blood samples were obtained after oral
ingestion of water solution with 75 g anhydrous glucose.
The glucose tolerance status was classified according
to the WHO criteria [38]. Individuals who had fasting
plasma glucose (FPG) level ≥ 126 mg/dl or 2 h plasma
glucose (2hPG) ≥ 200 mg/dl were classified as having
Type 2 diabetes mellitus. Those with 2hPG ≥ 140 mg/
dl but < 200 mg/dl, and FPG < 100 mg/dl were classified as having isolated IGT. Isolated IFG was defined as
FPG ≥ 110 but < 126 mg/dl, and 2hPG < 140 mg/dl. People
with 2hPG ≥ 140 mg/dl but < 200 mg/dl, and FPG ≥ 110
but < 126 mg/dl were defined as combined IGT and IFG.
Abnormal glucose tolerance was defined as T2D, IGT or
IFG. [38, 40].
Ethical aspects

This study followed the rules of good clinical practice and
guidelines of the Declaration of Helsinki. It was approved
by the ethics committee of the Universidad del Norte
(report 141 of 28 April 2016). Each participant signed the
informed consent before participating and could withdraw from the study at any time they preferred.
Statistical analysis

Categorical variables and frequency distributions by
health state were expressed in absolute numbers and
percentages with 95% confidence intervals (95% CI).
Quantitative variables were summarized by means and
standard deviations and the evaluation expressed on
a visual analog scale (EQ-VAS), with the most frequent
health states using density graphs. Normality of the
variables was verified through Kolmogorov–Smirnov
tests. The nonparametric U tests of Mann–Whitney and
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Kruskal–Wallis were used to evaluate statistical differences between subgroups, and the chi-square test (X2) for
differences in proportions (homogeneity test). To establish factors associated with presenting problems in the
quality-of-life dimensions of the EQ-5D-3L descriptive
system, several binary logistic regression models were
tested. In the logistic regression model, the dependent
variable was each domain of the quality-of-life questionnaire, previously dichotomized into no problems (level 1)
and with some problem (levels 2 and 3). To summarize
the data, only independent variables that showed a significant association with the quality-of-life dimensions
were reported. The results are presented according to
sex, city, and age group. p-values < 0.05 were considered
statistically significant. Processing and analysis of the
data were carried out using statistical software SPSS version 25 (SPSS; Chicago, IL, USA), with the density graphs
constructed using R version 4.0.0.

Table 1 Baseline characteristics of population at risk of T2D in
Barranquilla and Bogotá, Colombia in 2018

Results
Table 1 presents the baseline characteristics of the
study participants. The final study population included
1135 participants from two cities in Colombia (Barranquilla, n = 587; Bogotá D.C., n = 548). Of these, 54.6%
were older than 54 years, and the majority were women
(76.4%). The percentage of participants with prediabetes was 16% (n = 182), with more frequent occurrence in
participants from Barranquilla. The proportion of hidden
diabetes was 9%, with statistical equality between cities.
There was 87.7% of the population presenting overweight
or obese. Most participants had a low educational level
(no education or not finishing high school, 67.2%). The
proportion of participants with little physical activity was
larger in Barranquilla (91.7%). The percentages of current
smokers and those who reported receiving treatment for
hypertension were 7.8% and 38.5%, respectively.
The percentages of study participants expressing
problems in each dimension of the EQ-5D-3L description system are shown in Table 2. Altogether, 21.7%
reported mobility problems, 2.0% self-care, 15.1% daily
activities, 60.8% pain/discomfort, and 30.8% anxiety/
depression. The most frequent changes were the presence of moderate pain or discomfort (53.9%; 95% CI
51.0–56.8), followed by moderately anxiety or depression
(26.5%; 95% CI 24.0–29.2) and some problems walking.
Reports of moderate pain or discomfort were statistically more numerous among women, without differentiation between cities. The proportion of participants who
reported being moderately anxious or depressed was significantly higher among women and residents of Bogotá
D.C. The percentage of participants who had trouble
walking was larger among residents of Bogotá.

Variable

Total
City
1135 (100)
Barranquilla
587 (51.7)

Bogota D.C
548 (48.3)

Male

268 (23.6)

143 (24.4)

125 (22.8)

Female

867 (76.4)

444 (75.6)

423 (77.2)

30–44

226 (19.9)

140 (23.9)

86 (15.7)

45–54

289 (25.5)

168 (28.6)

121 (22.1)

55–64

338 (29.8)

164 (27.9)

174 (31.8)

> 64

282 (24.8)

115 (19.6)

167 (30.5)

p-valuea

Gender
0.539

Age groups (years)
< 0.001

Education level
No schooling

287 (25.3)

97 (16.5)

190 (34.7)

Elementary
school

475 (41.9)

247 (42.1)

228 (41.7)

Junior high
school

247 (21.8)

161 (27.4)

86 (15.7)

Higher

125 (11.0)

82 (14.0)

43 (7.9)

Low

854 (75.2)

538 (91.7)

316 (57.7)

Moderate

186 (16.4)

30 (5.1)

156 (28.5)

95 (8.4)

19 (3.2)

76 (13.9)

< 0.001

Physical activity

High

< 0.001

BMI (kg/m2)
Normal weight

140 (12.3)

67 (11.4)

73 (13.3)

Overweight

467 (41.1)

220 (37.5)

247 (45.1)

0.006

Obesity

528 (46.5)

300 (51.1)

228 (41.6)

182 (16.0)

110 (18.7)

72 (13.1)

102 (9.0)

63 (10.7)

39 (7.1)

437 (38.5)

226 (38.5)

211 (38.5)

0.999

88 (7.8)

24 (4.1)

64 (11.8)

< 0.001

Glucose classification
IFG, IGT or
IFG + IGT
T2D

0.002

Hypertension treatment
Yes
Current smokers
Yes
a

2

Homogeneity test (X ); n (%). BMI, body mass index; IFG, impaired fasting
glucose; IGT, impaired glucose tolerance; T2D, type 2 diabetes

Participants reported their health in 45 health states
(SQoL). However, of the 243 possible, 81.1% reported
their current health in only seven SQoL. Table 3 shows
the percentages of the most reported health states
(SQoL) in this study. The percentages are also shown by
sex and city. Most of the participants (69.4%) reported
some problem in the dimensions of the EQ-5D-3L questionnaire. The most reported health status was complete
health (SQoL: 11111, 30.6%; 95% CI 28.0–33.3), The
percentage of participants free of health complains was
statistically significantly higher in men than in women
(39% vs 28%), and those living in Barranquilla compared
with participants in Bogota (40% vs 20%). The second

2 (0.2)

612 (53.9)
78 (6.9)

I have moderate pain or discomfort

I have extreme pain or discomfort

301 (26.5)
49 (4.3)

I am moderately anxious or depressed

I am extremely anxious or depressed

*Difference is statistically significant at the 0.05 level

785 (69.2)

I am not anxious or depressed

Anxiety/depression

445 (39.2)

I have no pain or discomfort

Pain/discomfort

2 (0.2)

169 (14.9)

I have some problems with performing my usual activities

I am unable to perform my usual activities

964 (84.9)

I have no problems with performing my usual activities

Usual activities

21 (1.8)

I am unable to wash or dress myself

1112 (98.0)

I have some problems washing or dressing myself

I have no problems with self-care

Self-care

2 (0.2)

244 (21.5)

I am confined to bed

889 (78.3)

I have some problems walking about

n (%)

Total

I have no problems walking about

Mobility

Dimensions

3.3–5.7

24.0–29.2

66.4–71.8

5.5–8.5

51.0–56.8

36.4–42.1

0.05–0.64

12.9–17.1

82.7–86.9

0.05–0.60

1.2–2.8

97.0–98.7

0.05–0.60

19.2–24.0

75.8–80.6

95% CI

Table 2 Distribution of frequency response for each dimension of EQ-5D-3L

42 (4.8)

248 (28.6)

577 (66.6)

65 (7.5)

487 (56.2)

315 (36.3)

1 (0.1)

137 (15.8)

729 (84.1)

1 (0.1)

19 (2.2)

847 (97.7)

1 (0.1)

192 (22.2)

674 (77.7)

n (%)

95% CI

3.6–6.5

25.7–31.7

63.3–69.6

5.9–9.4

52.9–59.4

33.2–39.6

0.02–0.65

13.5–18.4

82.0–86.4

0.02–0.7

1.4–3.4

96.5–98.5

0.02–0.7

19.5–25.0

74.9–80.4

7 (2.6)

53 (19.8)

208 (77.6)

13 (4.9)

125 (46.6)

130 (48.5)

1 (0.4)

32 (11.9)

235 (87.7)

1 (0.4)

2 (0.7)

265 (98.9)

1 (0.4)

52 (19.4)

215 (80.2)

n (%)

95% CI

1.1–5.3

15.2–25.1 *

72.1–82.5 *

2.6–8.2

40.6–52.8 *

42.4–54.7 *

0.01–2.1

8.3–16.4

83.1–91.4

0.01–2.1

0.09–2.7

96.8–99.8

0.01–2.1

14.8–24.7

75.0–84.8

5 (0.9)

59 (10.1)

523 (89.1)

5 (0.7)

323 (55.0)

260 (44.3)

0 (0)

21 (3.6)

566 (96.4)

0 (0)

3 (0.5)

584 (99.5)

0 (0)

49 (8.3)

538 (91.7)

n (%)

Barranquilla

Female

Male

City

Gender

0.4–2.0

7.9–12.8

86.3–91.4

0.3–1.7

51.0–59.0

40.3–48.3

–

2.4–5.4

94.6–97.7

–

0.2–1.5

98.5–99.8

–

6.4–10.9

89.1–93.6

95% CI

44 (8.0)

242 (44.2)

262 (47.8)

74 (13.5)

289 (52.7)

185 (33.8)

2 (0.4)

148 (27.0)

398 (72.6)

2 (0.4)

18 (3.3)

528 (96.3)

2 (0.4)

195 (35.6)

351 (64.1)

n (%)

Bogota D.C

6.0–10.6*

40.1–48.3*

43.7–52.0*

10.9–16.6*

48.6–56.9

29.9–37.8*

0.1–1.3

23.5–30.9*

68.8–76.2*

0.1–1.3

2.1–5.1*

94.4–97.6*

0.1–1.3

31.7–39.7*

60.0–68.0*

95% CI
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Table 3 Assessment of current health state for population at risk of T2D, by gender and city
SQoL

Total
n = 1135
n (%)

Gender

City

Women
n = 867
95% CI

n (%)

Men
n = 268
95% CI

n (%)

Barranquilla
n = 587
95% CI

n (%)

Bogota D.C.
n = 548
95% CI

n (%)

95% CI

11111

347 (30.6)

28.0–33.3

243 (28.0)

25.1–31.1

104 (38.8)

32.9–44.9*

237 (40.4)

36.5–44.4

110 (20.1)

16.9–23.6*

11121

306 (27.0)

24.5–29.6

237 (27.3)

24.5–30.4

69 (25.8)

20.6–31.4

240 (40.9)

37.0–44.9

66 (12.0)

9.6–15.0*

11122

91 (8.0)

6.6–9.7

79 (9.1)

7.4–11.2

12 (4.5)

2.3–7.7*

31 (5.3)

3.8–7.4

60 (11.0)

8.6–13.8*

11112

57 (5.0)

3.9–6.5

44 (5.1)

3.8–6.7

13 (4.9)

2.6–8.2

12 (2.0)

1.2–3.5

45 (8.2)

6.2–10.8*

21222

45 (4.0)

3.0–5.3

35 (4.0)

2.9–5.6

10 (3.7)

1.8–6.8

3 (0.5)

0.2–1.5

42 (7.7)

5.7–10.2*

21121

42 (3.7)

2.8–5.0

33 (3.8)

2.7–5.3

9 (3.4)

1.6–6.3

23 (3.9)

2.6–5.8

19 (3.5)

2.2–5.4

21122
38 other states

32 (2.8)
215 (18.9)

2.0–4.0
16.8–21.3

26 (3.0)
170 (19.6)

2.1–4.4
17.1–22.4

6 (2.2)
45 (16.8)

0.8–4.8
12.5–21.8

7 (1.2)

0.6–2.4

25 (4.6)

34 (5.8)

4.2–8.0

181 (33.0)

3.1–6.7 *
29.2–37.1 *

*Statistically significant difference p-value < 0.05 (homogeneity test). 11111, without problems in all five dimensions; 11121, moderate pain/discomfort with no
problems in the other four dimensions; 11122, moderate pain/discomfort and moderate anxiety/depression without problems in the other three dimensions; 11112,
moderate anxiety/depression without problems in the other four dimensions; 21222, some trouble walking, no self-care problems, some trouble performing usual
activities, moderate pain/discomfort, and moderate anxiety/depression; 21121, some walking problems and moderate pain/discomfort with no problems in the other
three dimensions; 21122, some walking problems, moderate pain/discomfort and moderate anxiety/depression without problems in the other two dimensions

most reported health status was moderate pain or discomfort, with no problems in the other four dimensions
(SQoL: 11121, 27%; 95% CI 24.5–29.6), with similarity
by sex. However, a higher prevalence of moderate pain/
discomfort was found in participants in Barranquilla
compared with those in Bogotá (p-value < 0.05). Moderate pain / discomfort and moderate anxiety / depression
with no problems in the other dimensions (SQoL: 11122)
was presented 8% of the study participants. The SQoL:
11122 were more prevalent in women and those living
in Bogotá compared to their counterparts. The percentage of those who presented some walking problems and
moderate pain or discomfort without presenting problems in the other dimensions (SQoL: 21121) did not differ significantly by sex (3.8% vs 3.4%) and by city (3.9% vs
3.5%). Approximately 10% (n = 114) presented states with
more severe alterations (three in any of the dimensions),
a very large proportion compared to that found in the
general Colombian population [41].
The scores obtained on the EQ-VAS for the seven
most reported SQoLs show that the health state complete and states presenting moderate problems in one
of the dimensions of quality of life had higher scores, in
contrast to states presenting problems in more than one
dimension (left part of Fig. 1). The average score for the
complete health state was 79.3 ± 17.1 (SQoL: 11111),
and the corresponding value for women was smaller
than for men (p-value < 0.05). Similarly, women reported
statistically significantly smaller values in SQoL 11121
compared to men. For SQoLs 11122, 21121, 21122 and
21222, no significant differences were detected, except
in SQoL 21121 (some walking problems and moderate
pain or discomfort, without problems in the other three

dimensions), for which the average score was 53.3 ± 18
among men—statistically significantly smaller than the
score for women (73.2 ± 12.9) (see right part of Fig. 1).
Regarding living place, it was observed that the participants from Barranquilla (SQoL 11111) had lower values
for their health state compared with those from Bogotá
D.C., 78 ± 16.7 and 82.1 ± 17.6, respectively. For the other
six SQoLs, no statistically significant differences were
found in values determined by the EQ-VAS. The scores of
people older than 55 were comparable to those of participants of younger age-groups even when they reported no
health problems (Fig. 2).
Table 4 reveals the results of the logistic regression
models for each dimension of the EQ-5D-3L, in which
the city (OR 5.9; 95% CI 4.2–8.4), age (OR 2.5; 95% CI
1.8–3.5) and hypertension treatment (OR 1.6; 95% CI
1.2–2.2) were statistically significant predictors of MO.
In addition, living place (OR 8.2; 95% CI 2.4–27.9) and
impaired glucose tolerance (OR 2.4; 95% CI 1.04–5.8)
were associated with SC. Moreover, living place, age,
receipt of treatment for hypertension, and education
were associated with UA. The problems in the dimension of P/D was greater among participants from Bogotá
(OR = 1.6; 95% CI 1.2–2.0) and women (OR 1.6; 95% CI
1.2–2.2). The odds of A/D was nine times higher in participants from Bogotá (OR 9.1, 95% CI 6.6–12.4) compared with those from Barranquilla and almost twice as
in women (OR 1.9, 95% CI 1.3–2.7) than men.

Discussion
Our data indicate that gender, age, city, impaired glucose
tolerance, treatment for hypertension, and educational
level was associated with the HRQoL in people at risk of
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Fig. 1 Distribution of EQ-VAS score for most frequent health states in the population at risk of suffering T2D in Barranquilla and Bogotá, Colombia.
a
HRQoL distribution in the general population and by sex. *Statistically significant difference; T2D, type 2 diabetes; 11111, without problems in
all five dimensions; 11121, moderate pain/discomfort with no problems in the other four dimensions; 11122, moderate pain/discomfort and
moderate anxiety/depression without problems in the other three dimensions; 11112, moderate anxiety/depression without problems in the other
four dimensions; 21222, some trouble walking, no self-care problems, some trouble performing usual activities, moderate pain/discomfort, and
moderate anxiety/depression; 21121, some walking problems and moderate pain/discomfort with no problems in the other three dimensions;
21122, some walking problems, moderate pain/discomfort and moderate anxiety/depression, without problems in the other two dimensions

Fig. 2 Distribution of EQ-VAS score for the most frequent health states in the population at risk of T2D, according to city and age group. aHRQoL
distribution according to age group and city; *Statistically significant difference; T2D, type 2 diabetes; BAQ, Barranquilla; BOG, Bogotá; 11111,
without problems in all five dimensions; 11121, moderate pain/discomfort with no problems in the other four dimensions; 11122, moderate pain/
discomfort and moderate anxiety/depression without problems in the other three dimensions; 11112, moderate anxiety/depression without
problems in the other four dimensions; 21222, some trouble walking, no self-care problems, some trouble performing usual activities, moderate
pain/discomfort, and moderate anxiety/depression; 21121, some walking problems and moderate pain/discomfort with no problems in the other
three dimensions; 21122, some walking problems, moderate pain/discomfort and moderate anxiety/depression, with no problems in the other two
dimensions
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Table 4 Factors associated with presenting problems in the of quality of life dimensions for the population at risk of T2D in
Barranquilla and Bogota
Dependent variable

Characteristic

Mobility

City

B

SE

p-value

OR (95% CI)

Barranquilla (Ref.)
Bogota D.C

1.78

0.18

< 0.001

5.9 (4.2–8.4)

0.91

0.18

< 0.001

2.5 (1.8–3.5)

0.48

0.16

0.003

1.6 (1.2–2.2)

2.1

0.63

0.001

8.2 (2.4–27.9)

0.89

0.44

0.041

2.4 (1.04–5.8)

2.2

0.25

< 0.001

9.3 (5.7–15.2)

0.78

0.22

< 0.001

2.2 (1.4–3.3)

0.41

0.19

0.028

1.5 (1.05–2.2)

− 0.373

Age group
< 55 years (Ref.)
≥ 55 years

Hypertension treatment
No (Ref.)
Yes
Self-care

City
Barranquilla (Ref.)
Bogota D.C
Glucose classification
Normal (Ref.)
Impaired glucose tolerance

Usual activities

City
Barranquilla (Ref.)
Bogota D.C
Age group
< 55 years (Ref.)
≥ 55 years

Hypertension treatment
No (Ref.)
Yes
Education level
Superior (Ref.)
No schooling
Elementary school
Junior high school
Pain/discomfort

City

0.34

0.265

0.69 (0.36–1.3)

− 0.671

0.32

0.039

0.51 (0.27–0.97)

− 0.979

0.39

0.011

0.38 (0.18–0.8)

0.442

0.12

< 0.001

1.6 (1.2–2.0)

0.50

0.14

< 0.001

1.6 (1.2–2.2)

2.2

0.16

< 0.001

9.1 (6.6–12.4)

0.63

0.18

< 0.001

1.9 (1.3–2.7)

Barranquilla (Ref.)
Bogota D.C
Sex
Male (Ref.)
Female
Anxiety/depression

City
Barranquilla (Ref.)
Bogota D.C
Sex
Male (Ref.)
Female

a

OR, Odds Ratio; Ref, reference group

Pain/Discomfort and Anxiety/Depression are the qualityof-life dimensions with the most reported problems in
the population at risk of T2D, largely among female participants and residents of Bogotá (a large city). The most
frequent alterations to the quality-of-life dimensions in

this type of population were the presence of some type
of pain or discomfort, followed by anxiety or depression
and problems in walking.
To our knowledge, there have been no studies establishing HRQoL or reporting the most common alterations in
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the populations at risk of future diabetes using the EQ5D-3L in Colombia or South America. However, given
that patients with prediabetes are at risk of progressing
to the T2D and that many studies of patients with T2D
used the EQ-5D questionnaire, we may draw some comparison with previous studies. Our data established that
the dimension of quality of life with the greatest problem
in patients at risk of developing T2D is Pain/Discomfort,
which is in line with the current scientific evidence [15,
42, 43] revealing that patients with prediabetes (IFG)
presented greater problems in the dimensions of physical functioning and body pain, similar to that observed
by Tapp et al. in patients with IGT. Moreover, a prospective study using three different HRQoL questionnaires
(SF-36, SF-6D, and 15D) reported that the deterioration
of glycemic status negatively impacts the physical dimensions of HRQoL [43]. However, Seppälä et al. reported
that prediabetes was not associated with HRQoL [16].
Among studies that used the EQ-5D questionnaire for
populations with T2D, the results coincide with ours
[44–46]. The dimension with maximum reports of moderate or severe problems in patients with T2D was Pain/
Discomfort [44], consistent with the observations of Solli
et al. [45] and Javanbakht et al. [46]. Recent studies of
patients with diabetes confirmed that the most frequent
alteration in the dimensions of quality of life was Pain/
Discomfort [14, 47].
Several studies in patients with T2D have reported
that after the pain/discomfort dimension, the Anxiety/
Depression dimension was the second most reported
problems [14, 45, 46]. However, in the population at risk
of T2D, there is not enough scientific evidence to conclude that the presence of anxiety or depression is very
prevalent among patients with prediabetes. However,
it has been revealed that symptoms of depression were
greater in women with prediabetes compared with participants with normal glucose metabolism [48]. A study
in Greece using the 15D HRQoL questionnaire reported
that patients with IGT presented problems in the dimension of “anguish” [19]. Finally, another study concluded
that depression was more prevalent in people with T2D
or at high risk of diabetes [49]. In our study, a large proportion of subjects at risk of T2D reported problems
in the Mobility dimension, which is consistent with the
results of Sakamaki et al. [44] and Makrilakis et al. [19].
The mean score on the visual analog scale (EQVAS) of the participants in our study was 74.3 ± 17.3.
Unlike our study, previous research were all conducted
in patients with T2D. For instance, a study of 1224
patients with diabetes, revealed a mean score of the EQVAS equivalent to 68 ± 18.0 [11], whereas in the study
of Javanbakht et al., it was 56.8 (95% CI 56.15–57.5)
[43]. In other recent studies of patients with T2D, the

mean score on the same scale was 65.22 ± 9.32 [14] and
80 ± 12.9 [47], respectively. According to these results,
it may be asserted that the perception of quality of life
of patients at risk of future diabetes is better than those
who suffer from the disease. In the present analysis, the
female participants, despite presenting the same health
state as the men, yielded smaller values on the EQVAS in the generic quality of life questionnaire. Also,
women with T2D were found to have a poorer quality
of life than men [11, 14, 44, 46]. Despite presenting the
same complete health conditions as those from Bogotá,
the participants from Barranquilla had lower values on
the EQ-VAS. This agrees with the results of Rojas et al.,
who reported that citizens in the Atlantic region tended
to express lower values compared to the other regions
of Colombia [41]. Studies have shown that cities large
countries present better living conditions due to economic development and the potentialization of the
human condition that implies urban growth. However,
several authors maintain, a city is large, promotes processes of spatial segregation and social exclusion, initiating the path to degradation of the quality of life of its
inhabitants, since it is difficult to build a social fabric,
a fundamental element of cooperation, solidarity and
equity of a society important in the social determinants
of the Health; evidencing that the geopolitical distribution of cities presents inequalities in all areas essentials
of life that mark a diminished perception of the quality
of life of the inhabitants [50, 51].
According to Javanbakht et al. [46], people living in
larger cities are more likely to report problems in the
self-care dimension. Moreover, place of residence was
statistically significantly associated with the dimensions of Self-Care Usual Activities, and Anxiety/Depression in 300 patients with T2D in Birjand/Iran [14]. Sex
was associated with the Pain/Discomfort and Anxiety/
Depression dimensions, so women were more likely to
report greater problems in these dimensions than men.
This is agrees with findings in patients with T2D [11, 14,
46]. Alterations in the dimensions of Mobility and Usual
Activities were more frequently reported by older participants (55 years or more) as in other studies as well
[14, 46, 52]. These findings may be important for clinical
practice because the use of HRQoL measures to evaluate the health, satisfaction and well-being results of the
patient, provide an tool in the quality of patient care and
in the decision-making process. Therefore, knowing the
perception of quality of life (EQ-VAS), identifying factors related to HRQoL and having population scales are
essential to characterize and interpret aspects of interest in persons at risk of diabetes [53, 54]. We encourage
further inquiry into the HRQL of people at risk of diabetes, although we work with participants from lower
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socioeconomic strata, we recommend extending it to the
rest of the socioeconomic strata.
Naturally, our study has some limitations. First, a set of
values for the EQ-5D-3L in Colombia has not yet been
established. Therefore, we were unable to report here the
EQ-5D score or utility weights of the population at risk of
diabetes (We hope to estimate the EQ-5D score using the
set of values recommended for Colombia in future studies), and we were also unable to show the association or
significant differences between the EQ-5D and EQ-VAS
scores [9, 41]. The low sensitivity and ceiling effect of the
EQ-5D-3L compared to the 5-level version (EQ-5D-5L)
places another limitation on the responses of the participants [21–24]. However, we prefer to use the 3-level version because this study is part of the health economics
research to investigate the cost effectiveness of diabetes
prevention programs and the guidelines for economic
evaluation in Colombia recommend using the system
EQ-5D-3L [55]. Furthermore, all the participants in our
study belong to the lowest socioeconomic level. Therefore, our results do not allow us to generalize populations
with different socioeconomic levels or are not necessarily applicable to the general population. We also lacked
information on potentially useful clinical variables such
as comorbidities and current treatments of the patients,
which could behave as a confounding factor or have
effects on the HRQL found in this study. Finally, as it is
a cross-sectional study, the observed associations are not
necessarily causal.
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Conclusions
As sex, age, living place, impaired glucose tolerance,
treatment for hypertension, and educational level were
predictors of HRQoL in people at future risk of T2D,
greater attention should be paid to these determinants
in order to design, reorient and implement strategies
that to achieve better health outcomes. Due to the characteristics related to this study, studies are required in
populations of other socioeconomic strata that allow
extrapolating the results to the entire population at risk
of diabetes and identifying aspects of interest in this population. Nevertheless, future studies should focus on validating utility values in this type of population, estimating
HRQoL according to glycemic status and determining if
self-reported perceptions are consistent with the level of
utility of the participants.
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